PDCD1 and neoplasm: In the PD-1/PD-L1 pathway, PD-1 binds to PD-L1 on the surface of tumor cells and triggers the expression of SHP2, which inhibits PI3K/AKT signaling, leading to decreased T cell function and apoptosis.